leadf
logo-loader
viewPsyence Group Inc
(
CSE:PSYG
)

Psyence looking to be a major player in psychedelics using their federally licensed facilities

Psyence BioMed (CSE: PSYG) CEO Jody Aufrichtig joined Steve Darling from Proactive to shares news about this newly listed company that is one of the few to have built and operate a Federally licensed commercial psilocybin cultivation and production facilities.

Aufrichtig telling Proactive about that facility and how they plan to move forward with their Therapeutics, Production, Experience and Function

Quick facts: Psyence Group Inc

Follow
CSE:PSYG

Price: 0.185 CAD

Market Cap: $15.82 m

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of named herein, including the promotion by the Company of in any Content on the Site, the Company receives from said issuer annual cash...

FOR OUR FULL DISCLAIMER CLICK HERE

Psyence Group launches its functional mushroom products under the GOODMIND...

Psyence Group Inc (CSE:PSYG) (CSE:PSYG)'s Tony Budden caught up with Proactive New York to discuss the the international biotechnology company with operations in South Africa's launch of its range of functional mushroom products under the GOODMIND banner. Budden says the GOODMIND formula...

on 23/8/21

2 min read